Biolytica’s focus is its Biolytica NEXUS health data platform, a AI-driven analytics platform that aggregates, visualizes and analyzes data from genomics, blood and epigenetic biomarkers, as well as microbiome biomarkers, wearable devices, lifestyle data and more.
Biolytica has raised €5.3M across 1 funding round from 1 investor, most recently a round in May 2023. Based in Zug, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-02 | Other | €5.3M |
| Maximon Longevity Co-Investment Fund |
| View deal → |
